Evelyn Oberdorfer, 65, is a bodybuilder and half-marathon runner. She credits building her resilience from managing the highs and lows of type 1 diabetes since childhood.
Type 2 Diabetes News
Type 2 Diabetes is a chronic condition involving high blood sugar levels and reduced production and responsiveness to insulin.
112 readers recommended
While some affirm the health benefits of caffeine, like improving insulin sensitivity and blood sugar, research is mixed on whether it's detrimental for people with...
46 readers recommended
Join a study investigating BMF-219, a menin inhibitor that could stimulate healthy beta cell regeneration and potentially slow diabetes progression.
83 readers recommended
People with diabetes who are U.S. citizens or permanent residents can apply for a free lifetime America the Beautiful Pass, which offers access to over 2,000 parks,...
71 readers recommended
Medtronic unveils Simplera, the latest CGM approved in Europe for people with diabetes ages two and older. A sleek, disposable device, Simplera rivals the Dexcom G7 and...
104 readers recommended
Ongoing hostilities and violence across the world leave people with diabetes in crisis and without access to essential resources. What can be done to help?
52 readers recommended
Explore the profound issue of diabetes stigma and steps we can take to combat it. From the Language Matters movement to personal stories and global pledges, discover how...
37 readers recommended
This trial is investigating a new oral medication, INV-202, which is designed to improve regulation in the kidney, liver, and pancreas.
74 readers recommended
Data presented at EASD 2023 reveals orforglipron's potential in type 2 diabetes management. The new oral GLP-1 medication demonstrated significant reductions for A1C and...
41 readers recommended
Rising type 2 diabetes rates demand new approaches. The 2022 ADA/EASD Consensus Report emphasizes person-centered care, medications for glycemic control and weight loss...
50 readers recommended
Hypo-RESOLVE collaborates internationally to advance hypoglycemia understanding in diabetes. Evolving from a once-understudied concern, its Hypo-METRICS app now captures...
48 readers recommended
Survodutide, a GLP-1/glucagon dual receptor agonist, shows promising weight loss results in a clinical trial. The injectable medication, developed by Zealand and...
38 readers recommended
Experts addressed rising rates of cardiovascular disease in children with diabetes at EASD 2023, emphasizing prevention and finding new biomarkers for early...
156 readers recommended
New research from the ReTUNE study of people with type 2 diabetes at a normal weight by Dr. Roy Taylor, University of Newcastle, found that type 2 diabetes is not caused...
38 readers recommended
At the 59th European Association for the Study of Diabetes in Germany, an expert panel discussed the tremendous cardiovascular health benefits of limiting body weight...
128 readers recommended
Tirzepatide (sold as Mounjaro) is more effective than semaglutide (Ozempic) for both blood glucose control and weight loss, according to a new analysis.
59 readers recommended
Diabetic foot ulcers are a common and costly complication for people with diabetes. ON101 is a promising new topical treatment anticipated for FDA approval in the coming...
139 readers recommended
Living with type 1 diabetes for over two decades, the author shares a harrowing tale of an unexpected diabetic complication threatening her vision. Discover her journey...
79 readers recommended
The FDA is cautioning people that the diabetes medication Ozempic – commonly prescribed off-label for weight loss – may be linked to a rare but severe side effect.
83 readers recommended
Our team is on the way to Hamburg, Germany, to cover the latest in diabetes medications, research, and technology at the European Association for the Study of Diabetes...